Table 2: Baseline characteristics of subjects in the derivation and validation datasets for developing a model of hypertension among HIV patients on ART in Fako Division.
|
Characteristics |
Derivation dataset (n = 648) |
Validation dataset (n = 648) |
P value |
|
Gender (Female), n (%) |
414 (63.9) |
410 (63.3) |
0.813 |
|
Age (years), mean (SD) |
40.3 (5.3) |
40.7 (6.1) |
0.920 |
|
BMI (kg/m2), mean (SD) |
23.9 (4.1) |
24.3 (4.2) |
0.892 |
|
SBP (mmHg), mean (SD) |
115.9 (7.0) |
116.2 (7.3) |
0.851 |
|
DBP (mmHg), mean (SD) |
73.5 (6.2) |
73.7 (6.3) |
0.169 |
|
CD4 (cell/mm3), mean (SD) |
251.3 (10.3) |
258.6 (11.0) |
0.977 |
|
Monthly income (frs), mean (SD) |
55,223 (326) |
54,953 (236) |
0.602 |
|
Smoking, n (%) |
47 (7.3) |
65 (10.0) |
0.075 |
|
Alcohol consumption, n (%) |
252 (38.9) |
268 (41.4) |
0.365 |
|
Family history of HTN, n (%) |
73 (27.2) |
79 (27.1) |
0.961 |
|
WHO stage IV, n (%) |
143 (22.3) |
153 (23.6) |
0.898 |
|
TDF/3TC/EFV, n (%) |
608 (93.8) |
616 (95.1) |
0.752 |
|
No formal education, n (%) |
23 (3.5) |
17 (2.6) |
0.650 |
|
Married, n (%) |
278 (42.9) |
290 (44.8) |
0.602 |
BMI: Body Mass Index; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; TDF/3TC/EFV: Tenofovir disoproxil fumarate/lamivudine/Efavirenz.